Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration …
All Posts
The Future of Advanced Therapeutics: Opportunities and Challenges
The biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These …
Basetwo Raises $11.5M for AI-Driven, First-Principles Pharmaceutical Manufacturing Optimization
Basetwo, an AI platform for manufacturing engineers, has raised $11.5 million in Series A funding. The funding will support the …
Insilico Medicine Doses First Patient With AI-Designed Pan-TEAD Inhibitor
Insilico Medicine, a clinical-stage biotechnology company leveraging generative AI for drug discovery, has dosed the first patient in its global …
Advarra Launches Study Collaboration Solution to Accelerate Clinical Trial Startup
Advarra, a provider of regulatory review solutions and clinical research technology, has introduced its Study Collaboration solution, designed to streamline …
RyboDyn Uncovers Dark Proteome, Secures $4M Pre-Seed for Cancer Immunotherapy
RyboDyn, a biotechnology company targeting the “dark proteome,” has announced the discovery of a previously hidden human proteome and closed …
Icelandic Biotech Raises €26.5M for Clinical-Stage Dementia and Skin Disease Treatments
Arctic Therapeutics (ATx), an Icelandic drug discovery and development company, has closed an oversubscribed €26.5 million Series A financing round. …
Tempus Announces National Launch of AI-Powered Personal Health Assistant
Tempus AI, Inc. (NASDAQ: TEM) has launched olivia, an AI-enabled app designed to help patients organize and manage their health …
Study: Trust in Scientists Post-Pandemic Remains High, but Public Wants More Engagement
Led by researchers from Harvard University, ETH Zurich, and the University of Zurich, a recent international study sheds light on …
Mayo Clinic Partners with Microsoft and Cerebras on Radiology and Genomics Foundation Models
Mayo Clinic has announced collaborations with Microsoft Research and Cerebras Systems to explore the potential of generative artificial intelligence (AI) …
Longevity Company Rubedo Announces Phase 1 Trials for GPX4 Modulator Targeting Aging Cells and Surrounding Tissues
Rubedo Life Sciences has unveiled its clinical development plans for RLS-1496, a first-in-class GPX4 modulator, during the 12th Annual Dermatology …
Swiss Researchers Advance Spatial Proteomics with AI-Powered Virtual Tissue Foundation Model
Researchers from École Polytechnique Fédérale de Lausanne (EPFL) and ETH Zurich, in collaboration with the University Hospital Zurich and the University …